Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now — Oct 17th, 2024

Patterson Companies, Inc. PDCO is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further. In...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...